Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan-Reference-Cited by-同舟云学术

Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan

Published:2023-02 Issue:2 Volume:78 Page:281-292
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Tsai Pei-Chien^ORCID,Kuo Hsing-Tao^ORCID,Hung Chao-Hung,Tseng Kuo-Chih,Lai Hsueh-Chou,Peng Cheng-Yuan,Wang Jing-Houng,Chen Jyh-Jou,Lee Pei-Lun,Chien Rong-Nan,Yang Chi-Chieh,Lo Gin-Ho,Kao Jia-Horng,Liu Chun-Jen,Liu Chen-Hua,Yan Sheng-Lei,Bair Ming-Jong,Lin Chun-Yen,Su Wei-Wen^ORCID,Chu Cheng-Hsin,Chen Chih-Jen^ORCID,Tung Shui-Yi,Tai Chi-Ming,Lin Chih-Wen,Lo Ching-Chu^ORCID,Cheng Pin-Nan^ORCID,Chiu Yen-Cheng,Wang Chia-Chi,Cheng Jin-Shiung,Tsai Wei-Lun^ORCID,Lin Han-Chieh,Huang Yi-Hsiang^ORCID,Yeh Ming-Lun^ORCID,Huang Chung-Feng,Hsieh Meng-Hsuan^ORCID,Huang Jee-Fu^ORCID,Dai Chia-Yen,Chung Wan-Long^ORCID,Chen Chi-Yi,Yu Ming-Lung

Publisher

Elsevier BV

Subject

Hepatology

Reference48 articles.

1. Management of hepatocellular carcinoma;J Hepatol,2018

2. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015;Akinyemiju;JAMA Oncol,2017

3. Effects of cirrhosis and diagnosis scenario in metabolic-associated fatty liver disease-related hepatocellular carcinoma;Chen;Hepatol Commun,2021

4. Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis;Lin;J Hepatol,2013

5. Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients;Liu;Hepatol Int,2021

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD);Journal of Hepatology;2024-09

2. Metabolic dysfunction-associated steatotic liver disease and diabetes: the cross-talk between hepatologist and diabetologist;Expert Review of Gastroenterology & Hepatology;2024-08-02

3. Hepatitis C virus and hepatocellular carcinoma: carcinogenesis in the era of direct-acting antivirals;Current Opinion in Virology;2024-08

4. Metformin as adjuvant treatment in hepatitis C virus infections and associated complications;The American Journal of the Medical Sciences;2024-08

5. AI‐powered prediction of HCC recurrence after surgical resection: Personalised intervention opportunities using patient‐specific risk factors;Liver International;2024-07-24